Shanghai Fosun Pharmaceutical (Group) Co., Ltd., 10% Owner at CONTRAFECT Corp (CFRX), sold 600,000 shares at $2.04 ($1.2M) on 2018-12-04, disclosed to the SEC on 2018-12-06.
Open-market sale of $1.2M CFRX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |